4//SEC Filing
Begor Mark W 4
Accession 0001225208-25-006893
CIK 0000033185other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:20 PM ET
Size
20.5 KB
Accession
0001225208-25-006893
Insider Transaction Report
Form 4
EQUIFAX INCEFX
Begor Mark W
DirectorCEO
Transactions
- Sale
Common Stock
2025-07-28$243.90/sh−831$202,684→ 189,941 total - Exercise/Conversion
Stock Option/Right to Buy
2025-07-28−27,960→ 27,959 totalExercise: $191.44Exp: 2026-02-21→ Common Stock (27,960 underlying) - Exercise/Conversion
Common Stock
2025-07-28$191.44/sh+27,960$5,352,662→ 191,136 total - Sale
Common Stock
2025-07-28$244.95/sh−364$89,161→ 190,772 total - Sale
Common Stock
2025-07-28$242.70/sh−9,497$2,304,935→ 180,444 total - Sale
Common Stock
2025-07-28$241.87/sh−17,731$4,288,620→ 162,713 total - Sale
Common Stock
2025-07-28$240.95/sh−19,841$4,780,614→ 142,872 total
Holdings
- 9,525(indirect: 2-yr Feb 2024 GRAT)
Common Stock
- 11,380(indirect: 2-yr Jul 2024 GRAT)
Common Stock
- 43,431(indirect: 2-yr Jun 2025 GRAT)
Common Stock
- 10,500(indirect: 2-yr 2025 GRAT)
Common Stock
- 12,333(indirect: 2-yr May 2025 GRAT)
Common Stock
- 16,287(indirect: 3-yr Jul 2024 GRAT)
Common Stock
Footnotes (8)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/14/2024.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $244.72 to $245.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F3]Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 199 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- [F4]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $243.47 to $244.44, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F5]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $242.41 to $243.17, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F6]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $241.41 to $242.40, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F7]The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $240.40 to $241.39, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- [F8]The option vested in three equal annual increments beginning 2/21/2021.
Documents
Issuer
EQUIFAX INC
CIK 0000033185
Entity typeother
Related Parties
1- filerCIK 0001335111
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:20 PM ET
- Size
- 20.5 KB